PDL
EW icon

Portfolio Design Labs’s Edwards Lifesciences EW Stock Holding History

Portfolio Design Labs’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
2,686
+18
+0.7% +$1.51K 0.04% 209
2026
Q1 		$214K Buy
+2,668
New +$220K 0.04% 227

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Portfolio Design Labs's EW Position: Q2 2026 in Review

Portfolio Design Labs increased its Edwards Lifesciences (EW) stake by 0.67% in Q2 2026, buying an estimated $1.51K and bringing the position to 2,686 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #209.

Portfolio Design Labs first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Portfolio Design Labs held 2,686 shares of Edwards Lifesciences worth $243K as of Q2 2026.
  • Portfolio Design Labs bought 18 Edwards Lifesciences shares in Q2 2026, an estimated $1.51K.
  • Edwards Lifesciences made up 0.04% of Portfolio Design Labs's portfolio in Q2 2026, its #209 holding.
  • Portfolio Design Labs first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.